Constructive Bio has been shortlisted for the One Nucleus Awards 2026 in the best use of emerging technology category for its whole-genome synthesis and engineered translation platform. Constructive Bio has been shortlisted for the One Nucleus Awards 2026 in the best use of emerging technology category. The shortlist recognises Constructive Bio’s whole-genome synthesis platform combined…
Constructive Bio won the Life Science Scale-Up Award at the 35th Anniversary Business Weekly Awards in Cambridge, recognising the company’s…
Constructive Bio was Highly Commended in the Biotech Company of the Year category at the Cambridge Independent Science and Technology…
Constructive Bio founder and CSO Professor Jason Chin received the SynBioBeta 2025 Impact Award, recognising his contributions to synthetic biology…
The Sunday Times named Constructive Bio a ‘Biotech One to Watch’ in its 2025 100 Tech Awards, recognising the Cambridge-based…
Constructive Bio was named Best Performing R&D Platform Development Company of the Year at the One Nucleus Awards, recognising the…
Engineering the future of biology with revolutionary genome synthesis and expanded genetic code technology.
QUICK LINKS
JOIN OUR NEWSLETTER
© 2026 Constructive Bio. All rights reserved.